“The FAST TRACK evaluation service has allowed us to increase private promoters’ power of attraction and launch projects in no time. Rapidly getting approval to launch Roche’s ProHer study and Sanofi’s Phase I – II study will allow the researchers, namely Dr. Lemieux and her team, to begin recruiting and, above all, to offer the drug to users quickly.”
